/People

Tom Thomas

Investor

Principal at Newpath Partners · Therapeutics Advisory Panel, UCLA Innovation Fund at UCLA Ventures

Boston, Massachusetts

Writes $500K – $40M checks · typically $15M

Find your path to Tom

759 people in our graph can introduce you to Tom.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Eva Ho to introduce you to Tom

You →Eva · together at UCLA Ventures (2025–2026) →Tom

Ask Jamie Chen to introduce you to Tom

You →Jamie · 6 people · together at Cedars-Sinai →Tom

Ask Sam Okafor to introduce you to Tom

You →Sam · 5 people · together at Cleveland Clinic →Tom

Sign up to find every way you can get introduced to Tom

  • Your email: the people you already email who know Tom
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Tom
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.

Experience

  1. CREATE MedicinesBoard Directorcurrent2026 — present
  2. Cleveland ClinicExternal Advisory Councilcurrent2026 — present
  3. Newpath PartnersInvestor, Principalcurrent2024 — present
  4. UCLA Technology Development GroupTherapeutics Advisory Panel, UCLA Innovation Fundcurrent2025 — present
  5. Magnet BiomedicineBoard Observercurrent2024 — present
  6. Exo TherapeuticsBoard Directorcurrent2024 — present
  7. Kisbee TherapeuticsBoard Observer2024 — 2025
  8. Sera Medicines, LLCFounding Team2023 — 2024
  9. RA Capital Management, L.P.Healthcare Associate2022 — 2024Boston, Massachusetts, United States
  10. Prologue MedicinesFounding Team2021 — 2022
  11. Flagship PioneeringAssociate2020 — 2022Cambridge, Massachusetts, United States
  12. Flagship PioneeringFellow2020Cambridge, Massachusetts, United States
  13. Emmanuel College (Boston)Adjunct Faculty of Biology2018 — 2020Greater Boston Area
  14. Harvard Medical SchoolResearch Fellow2017 — 2020Boston, Massachusetts, United States
  15. Cedars-SinaiPh.D Candidate, Cancer Biology2013 — 2017
  16. University of California, Los AngelesResearch Associate2008 — 2011Los Angeles, California, United States
  17. Scripps ResearchResearch Intern2005 — 2006

Skills & more

Board GovernanceCorporate StrategyProject Portfolio ManagementStart-up VenturesStart-up LeadershipEarly Stage InvestmentNew Venture DevelopmentCell Culture12Molecular Biology9Genetics4Clinical Research7Research5
+11 moreBiochemistryCancer ResearchCancerTumor ImmunologyStem Cell ResearchCancer Stem CellsTissue CultureMetabolismMicrosoft OfficeHealthcare InvestingCell Biology

Languages English · Malayalam · Spanish

  • Health Care Economics — Harvard Business School
  • Healthcare Innovation & Commercialization — Harvard Medical School

From Tom's professional profile.

Colleagues at Newpath Partners

Frequently asked questions

Who is Tom Thomas?
Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.
Where does Tom Thomas work?
Tom Thomas is Principal at Newpath Partners.
What check size does Tom Thomas write?
Tom Thomas typically writes checks of $500K – $40M.
Where did Tom Thomas go to school?
Tom Thomas studied at Harvard Medical School (Postdoctoral Fellowship, Molecular Pathology & Oncology); Cedars-Sinai Medical Center (Ph.D., Biomedical Science and Translational Medicine); UCLA (B.S., Physiological Sciences).

Same school

Shared employers